1-1 of 1
Authors: Udayasankar Arulmani
Journal Article
20 ETROLIZUMAB IMPROVED ENDOSCOPIC SCORE, PATIENT-REPORTED OUTCOMES, AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH MODERATE TO SEVERE UC WHO HAD FAILED TNF ANTAGONIST THERAPY: THE HICKORY OPEN-LABEL INDUCTION (OLI) COHORT Get access
Inflammatory Bowel Diseases, Volume 24, Issue suppl_1, February 2018, Page S12, https://doi.org/10.1093/ibd/izy019.038
Published: 18 January 2018
